Pharmacokinetics of a novel human intravenous immunoglobulin 10% in patients with primary immunodeficiency diseases: Analysis of a phase III, multicentre, prospective, open-label study
Under a Creative Commons license
open access
Graphical abstract
Keywords
Intravenous immunoglobulin
IVIG
Panzyga®
Pharmacokinetics
Primary antibody deficiencies
Cited by (0)
© 2018 The Authors. Published by Elsevier B.V.